Melissa Burgess - Dissemin

All papers authored by Melissa Burgess

This paper was not found in any repository, but could be made available legally by the author.

2024 Megan L. Zilla

, Dimitrios Korentzelos

, Jacob Lebamoff, Melissa A. Burgess

, Rana Naous

, Ivy John

ALX4::NCOA2 rearranged round and spindle cell sarcoma

Upload

Scott M. Schuetze

, Karla V. Ballman

, Rachel Heise

, Kristen N. Ganjoo

, Elizabeth J. Davis

, Suzanne George

, Melissa A. Burgess

, Edwin Choy

, Dale R. Shepard

, Gabriel Tinoco

, Angela Hirbe

, Ciara M. Kelly

, Steven Attia

, Hari A. Deshpande

, Gary K. Schwartz

and 7 other authors

A Single-Arm Phase 2 Trial of Trametinib in Patients with Locally Advanced or Metastatic Epithelioid Hemangioendothelioma

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

2023 Patrick Schöffski, Rastislav Bahleda, Andrew J. Wagner, Melissa A. Burgess

, Niels Junker, Michael Chisamore

, Patrick Peterson, Anna M. Szpurka, Matteo Ceccarelli

, William D. Tap

Table S4 from Results of an Open-label, Phase Ia/b Study of Pembrolizumab plus Olaratumab in Patients with Unresectable, Locally Advanced, or Metastatic Soft-Tissue Sarcoma

Upload

This paper is made freely available by the publisher.

Matthew Ingham

, Jacob B. Allred, Li Chen, Biswasjit Das

, Bose Kochupurakkal

, Katherine Gano, Suzanne George

, Steven Attia

, Melissa A. Burgess

, Mahesh Seetharam, Sosipatros A. Boikos, Nam Bui

, James L. Chen

, Julia L. Close, Gregory M. Cote

and 7 other authors

Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250)

Download from doi.org

Patrick Schöffski, Rastislav Bahleda, Andrew J. Wagner, Melissa A. Burgess

, Niels Junker, Michael Chisamore

, Patrick Peterson, Anna M. Szpurka, Matteo Ceccarelli

, William D. Tap

Figure S2 from Results of an Open-label, Phase Ia/b Study of Pembrolizumab plus Olaratumab in Patients with Unresectable, Locally Advanced, or Metastatic Soft-Tissue Sarcoma

Upload

Patrick Schöffski, Rastislav Bahleda, Andrew J. Wagner, Melissa A. Burgess

, Niels Junker, Michael Chisamore

, Patrick Peterson, Anna M. Szpurka, Matteo Ceccarelli

, William D. Tap

Figure S1 from Results of an Open-label, Phase Ia/b Study of Pembrolizumab plus Olaratumab in Patients with Unresectable, Locally Advanced, or Metastatic Soft-Tissue Sarcoma

Upload

Patrick Schöffski, Rastislav Bahleda, Andrew J. Wagner, Melissa A. Burgess

, Niels Junker, Michael Chisamore

, Patrick Peterson, Anna M. Szpurka, Matteo Ceccarelli

, William D. Tap

Data from Results of an Open-label, Phase Ia/b Study of Pembrolizumab plus Olaratumab in Patients with Unresectable, Locally Advanced, or Metastatic Soft-Tissue Sarcoma

Upload

Patrick Schöffski, Rastislav Bahleda, Andrew J. Wagner, Melissa A. Burgess

, Niels Junker, Michael Chisamore

, Patrick Peterson, Anna M. Szpurka, Matteo Ceccarelli

, William D. Tap

Table S2 from Results of an Open-label, Phase Ia/b Study of Pembrolizumab plus Olaratumab in Patients with Unresectable, Locally Advanced, or Metastatic Soft-Tissue Sarcoma

Upload

Patrick Schöffski, Rastislav Bahleda, Andrew J. Wagner, Melissa A. Burgess

, Niels Junker, Michael Chisamore

, Patrick Peterson, Anna M. Szpurka, Matteo Ceccarelli

, William D. Tap

Table S1 from Results of an Open-label, Phase Ia/b Study of Pembrolizumab plus Olaratumab in Patients with Unresectable, Locally Advanced, or Metastatic Soft-Tissue Sarcoma

Upload

Patrick Schöffski, Rastislav Bahleda, Andrew J. Wagner, Melissa A. Burgess

, Niels Junker, Michael Chisamore

, Patrick Peterson, Anna M. Szpurka, Matteo Ceccarelli

, William D. Tap

Table S3 from Results of an Open-label, Phase Ia/b Study of Pembrolizumab plus Olaratumab in Patients with Unresectable, Locally Advanced, or Metastatic Soft-Tissue Sarcoma

Upload

Irantzu Anzar, Brandon Malone, Pubudu Samarakoon, Ioannis Vardaxis, Boris Simovski, Hugues Fontenelle, Leonardo A. Meza Zepeda, Richard Stratford, Emily Z. Keung, Melissa Burgess

, Hussein A. Tawbi, Ola Myklebost, Trevor Clancy

The interplay between neoantigens and immune cells in sarcomas treated with checkpoint inhibition

Upload

Anthony R. Cillo, Elina Mukherjee, Nathanael G. Bailey, Sayali Onkar, Jessica Daley, Claudia Salgado, Xiang Li, Dongyan Liu, Sarangarajan Ranganathan, Melissa Burgess

, John Sembrat, Kurt Weiss, Rebecca Watters, Tullia C. Bruno, Dario A. A. Vignali and 1 other authors

Supplementary Figure from Ewing Sarcoma and Osteosarcoma Have Distinct Immune Signatures and Intercellular Communication Networks

Upload

Anthony R. Cillo, Elina Mukherjee, Nathanael G. Bailey, Sayali Onkar, Jessica Daley, Claudia Salgado, Xiang Li, Dongyan Liu, Sarangarajan Ranganathan, Melissa Burgess

, John Sembrat, Kurt Weiss, Rebecca Watters, Tullia C. Bruno, Dario A. A. Vignali and 1 other authors

Supplementary Table from Ewing Sarcoma and Osteosarcoma Have Distinct Immune Signatures and Intercellular Communication Networks

Upload

Anthony R. Cillo, Elina Mukherjee, Nathanael G. Bailey, Sayali Onkar, Jessica Daley, Claudia Salgado, Xiang Li, Dongyan Liu, Sarangarajan Ranganathan, Melissa Burgess

, John Sembrat, Kurt Weiss, Rebecca Watters, Tullia C. Bruno, Dario A. A. Vignali and 1 other authors

Data from Ewing Sarcoma and Osteosarcoma Have Distinct Immune Signatures and Intercellular Communication Networks

Upload

2022 Anthony R. Cillo

, Elina Mukherjee

, Nathanael G. Bailey

, Sayali Onkar

, Jessica Daley

, Claudia Salgado

, Xiang Li

, Dongyan Liu

, Sarangarajan Ranganathan

, Melissa Burgess

, John Sembrat

, Kurt Weiss

, Rebecca Watters

, Tullia C. Bruno

, Dario A. A. Vignali

and 1 other authors

Ewing Sarcoma and Osteosarcoma Have Distinct Immune Signatures and Intercellular Communication Networks

Upload

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

All papers authored by Melissa Burgess